Please try another search
Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the recommended phase 2 dose for further development in endometrial cancer; and oral rigosertib, which is administered alone or in combination for investigation in various cancers. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Alan R. Williamson | 87 | 2016 | Chairman of Scientific Advisory Board |
Jack E. Stover | 71 | 2016 | Independent Director |
Werner Cautreels | 72 | 2024 | CEO & Director |
Nikolay Savchuk | - | 2024 | COO & Director |
Iain D. Dukes | 66 | 2024 | Executive Chairman |
Mary Theresa Shoemaker | 62 | 2020 | Independent Director |
George F. Vande Woude | - | - | Member of Scientific Advisory Board |
Stephen D. Nimer | 69 | 2005 | Member of Scientific Advisory Board |
David Ross Parkinson | 74 | - | Member of Scientific Advisory Board |
Anna Marie Skalka | - | - | Member of Scientific Advisory Board |
James J. Marino | 74 | 2015 | Independent Director |
Ross C. Donehower | - | - | Member of Scientific Advisory Board |
Trafford Clarke | 65 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review